Founded Year



Series E | Alive

Total Raised




Last Raised

$153M | 1 yr ago

Mosaic Score

+10 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Evidation

Evidation measures health in everyday life and enables anyone to participate in research and health programs. Evidation is a two-sided platform that connects individuals and enterprises. On the consumer side, the company assists individuals to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, med-tech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.

Evidation Headquarter Location

400 Concar Drive

San Mateo, California, 94402,

United States


ESPs containing Evidation

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare / Healthcare Providers Tech

Companies in this market develop software that collects, analyzes, and aggregates clinical and claims data from multiple sources to identify population-level trends. Payers and providers use these solutions to spot high-cost and high-risk patients, design interventions, and track clinical quality and cost performance across specific populations.

Evidation named as Leader among 14 other companies, including Syapse, Aetion, and Clarify Health.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Evidation's Products & Differentiation

See Evidation's products and how their products differentiate from alternatives and competitors

  • Research

    Evidation runs programs for enterprises to get actionable evidence in three areas: disease burden and patient impact, patient segmentation and identification, disease event and progression modelling. We deploy a proven approach, incorporating our experience with over 200 research programs, to reliably delivers results. Given our connectivity with highly engaged individuals, we deliver faster and more cost-effectively.

Expert Collections containing Evidation

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Evidation is included in 10 Expert Collections, including Unicorns- Billion Dollar Startups.


Unicorns- Billion Dollar Startups

1,178 items


Clinical Trials Tech

329 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Value-Based Care & Population Health

1,049 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.


Biopharma Tech

16,121 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Evidation Patents

Evidation has filed 3 patents.

The 3 most popular patent topics include:

  • Activity trackers
  • Epidemiology
  • Health informatics
patents chart

Application Date

Grant Date


Related Topics



Smartwatches, Health informatics, Wearable devices, Wearable computers, Activity trackers


Application Date


Grant Date


Related Topics

Smartwatches, Health informatics, Wearable devices, Wearable computers, Activity trackers



Latest Evidation News

11:39 EDT YourBio Health: Partner in the Decentralization of Clinical Trials

Aug 4, 2022

News provided by Share this article - At-home blood collection facilitates patient participation in COVID-19 study - BOSTON, Aug. 4, 2022 /PRNewswire/ -- YourBio Health, Inc., developers of the world's first painless push-button blood collection device, was identified as a key contributor in the recent preprint published report in medRxiv. The report describes a trial conducted by Moderna, Inc. and Evidation Health in which YourBio Health enabled the measurement of "Antibody Response Following COVID-19 Boosters During the Omicron Wave in the US: A Decentralized, Digital Health, Real World Study". In the report, the Moderna authors noted that the combination of digital technology with remote blood collection methodologies may be a "first of its kind to utilize decentralization procedures to assess real world immunogenicity" where "participants collected blood using the YourBio TAP II device. "    This novel approach to measuring antibody response to COVID-19 boosters during the Omicron wave in the United States (U.S.) "sets a precedent for greater research access using a digital platform and consumer-directed technology", specifically, Evidation Health's digital health community and The YourBio Health Tap II blood collection device. "We are thrilled to have been a part of this breakthrough approach of completely decentralized clinical trials. The on-demand requirements of the trial population showed that we can enroll individuals from any location across the U.S.  Our technology eliminates barriers to blood collection by removing the need to schedule a blood draw and commute to a collection center, and by avoiding the pain and fear from finger sticks and phlebotomy. In addition to being an alternative to mobile phlebotomy, we can deliver more data across more patients at lower cost." said Harry Wilcox, Executive Chairman and CEO of YourBio Health. "Like Moderna and Evidation Health, we believe a new precedent has been set paving the way to enable more equitable participant enrollment while delivering data in a timely fashion. "                                                                                                                                   About YourBio Health YourBio Health eliminates barriers to blood collection by allowing a patient blood sample to be collected from any location without the pain of a fingerstick or need for traditional phlebotomy. We enable the decentralization of clinical trials and access to companies who offer wellness testing for consumers with the innovative TAP II Blood Collection Device. It is virtually painless, easy-to-use and enables the collection of a blood specimen from any setting – clinical or in-home. Backed by the latest science, data management technology, and certified central laboratories, we guarantee best-in-class test results. YourBio Health was founded by Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability. Since its launch in 2000, the firm has, through its Flagship Labs unit, applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $100 billion in aggregate value.

Evidation Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Evidation Rank

  • When was Evidation founded?

    Evidation was founded in 2012.

  • Where is Evidation's headquarters?

    Evidation's headquarters is located at 400 Concar Drive, San Mateo.

  • What is Evidation's latest funding round?

    Evidation's latest funding round is Series E.

  • How much did Evidation raise?

    Evidation raised a total of $259.18M.

  • Who are the investors of Evidation?

    Investors of Evidation include B Capital Group, McKesson Ventures, OMERS Private Equity, Kaiser Permanente Ventures, SV Health Investors and 12 more.

  • Who are Evidation's competitors?

    Competitors of Evidation include Syapse, Abacus Insights, Owkin, Curebase, Lumiata, Reify Health, Clareto, Clarify Health,, ConcertAI and 47 more.

  • What products does Evidation offer?

    Evidation's products include Research.

You May Also Like

Aetion Logo

Aetion delivers real-world evidence for life sciences companies, payers, at-risk providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce rapid and scientifically validated answers on treatments, costs, and outcomes. Aetion informs health care's most critical decisions - what works best, for whom, and when - to guide treatment development, commercialization, and payment values into health care's modern era.

Syapse Logo

Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations. The company was formerly known as BDLicense. Syapse was founded in 2008 and is based in San Francisco, California.

Clarify Health Logo
Clarify Health

Clarify Health collects records of rendered healthcare in the United States for the purpose of providing more granular and precise analytics to healthcare organizations, spanning from providers to payers and life sciences. Clarify's software solutions are fueled by a patient-level data set and incorporate clinical, claim, prescription, lab and socio-behavioral determinants of health data. Its analytics platform is powered by a technology stack inspired by those used in banking and logistics and provides doctors and insurers greater visibility into cost, quality, referrals, utilization, and member risk. The company is also helping life sciences organizations analyze and integrate rich data to determine the optimal sites and designs for clinical trials as well as accelerate clinical development timelines. The company was founded in 2015 and is based in San Francisco, California.

Springbuk Logo

Springbuk is a population health solution for employers, brokers and onsite clinics. Springbuk's cloud-based health intelligence platform combines medical claims, pharmacy, biometric, payroll and activity data for accurate and timely insights. This intelligence allows employers to measure health programs, identify at-risk members and engage with confidence.

HealthVerity Logo

HealthVerity provides technologies and software tools for the discovery and integration of optimal patient data sets. The company works with pharmaceuticals, hospitals, and payer customers to maximize the insights from data supplier relationships.


OM1 develops a data analytics platform to predict the outcomes of patients so that hospitals, healthcare systems, and other stakeholders can make better decisions about how to care for those patients. The company serves the healthcare industry. It was founded in 2015 and is based in Boston, Massachusetts.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.